Abstract

Biomedical research is at a turning point. Single cell technologies are opening extraordinary opportunities to address today’s medical challenges. These new tools will enhance our molecular understanding of functional cell states. They will give us major insights into when, how and why diseases of all kinds arise. Working at the cutting edge of this field, VIB has teamed up with LifeTime, a pan-European research initiative that wants to combine single-cell multi-omics, advanced imaging, artificial intelligence/machine learning and personalized disease models to fundamentally change the current medical practice. At the first edition of Emerging Technologies in Single Cell research, a two-day conference, VIB and LifeTime will bring together top researchers in the fields of multi-omics and artificial intelligence.